SARS-CoV-2-IN-110
Product Specifications
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
SARS-CoV-2-IN-110 (compound Bb1) is an inhibitor of SARS-CoV-2, demonstrating antiviral efficacy with an EC50 of 1.10 μM, and significantly reduced toxicity compared to Lapatinib. The compound exhibits a CC50 of greater than 100 μM against SARS-CoV-2, with a selectivity index (SI) exceeding 91.
Molecular Formula
C28H20ClFN4O2
Molecular Weight
498.94
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6413404-01 0.1 mL
CYP17A1 (Cytochrome P450 17A1, CPT7, CYP17, P450C17, S17AH, CYP17A1) (MaxLight 750)
Sign In for Pricing
View Details MBS6413404-02 5x 0.1 mL
CYP17A1 (Cytochrome P450 17A1, CPT7, CYP17, P450C17, S17AH, CYP17A1) (MaxLight 750)
Sign In for Pricing
View Details 
MBS6323228-01 0.1 mL
MYCT1, CT (MYCT1, MTLC, MTMC1, Myc target protein 1, Myc target in myeloid cells protein 1) (MaxLight 650)
Sign In for Pricing
View Details MBS6323228-02 5x 0.1 mL
MYCT1, CT (MYCT1, MTLC, MTMC1, Myc target protein 1, Myc target in myeloid cells protein 1) (MaxLight 650)
Sign In for Pricing
View Details 
13569111 3x 1.0 µg
BTNL2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details